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10 years.1 It is a heterogeneous group of conditions of un-
known etiology, each of which has specific clinical features 
and prognostic implications.2 It is one of the major causes of 
short- and long-term morbidity, and growth impairment is 
one of the complications, especially in polyarticular and sys-
temic JRA.3 Poor nutritional status has also been reported 
in adult rheumatoid arthritis patients. The body mass index 
(BMI) in men and women are significantly reduced in rheu-
matoid arthritis patients compared with controls.4
There are several measures which can be used to assess 
growth disturbance and nutritional impairment, such as 
height, weight, mid-upper arm circumference and the four 
skinfolds,5 biochemical abnormalities,6 and bioelectrical 
impedance,7 but these measures are not optimal methods 
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BACKGROUND/PURPOSE: The aim of the study was to investigate the clinical characteristics and nu-
tritional status of juvenile rheumatoid arthritis (JRA) in Taiwanese children.
METHODS: Fifty-three patients were included in this study. The disease subtype and patient characteris-
tics were recorded. Body mass index (BMI) was determined. Seventy-five healthy age-matched children 
served as a control group.
RESULTS: The inflammation parameters, including white blood cell count, platelet count, C-reactive 
protein, and erythrocyte sedimentation rate, were elevated in the systemic group. The BMI level of the JRA 
group was significantly lower than the control group (p = 0.006), especially in the male patients (p = 0.016) 
and when the patient age was greater than 4 (p = 0.011). The patients with oligoarticular onset JRA had 
significantly lower BMI compared with the healthy control group (p = 0.012).
CONCLUSION: Nutritional status is often impaired in patients with JRA. The BMI of the JRA patients 
was lower than that of age-matched healthy children, especially in the male group, and when disease onset age 
was greater than 4. In our unselected sample, the most affected disease subtype was oligoarticular onset JRA.
KEYWORDS: body mass index, juvenile rheumatoid arthritis, nutritional status
Introduction
Juvenile rheumatoid arthritis (JRA) is one of the most com-
mon pediatric rheumatic diseases, with peak age at 4 and 
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for the evaluation of nutritional status in clinical practice. 
The BMI provides a valid measure of fatness in healthy 
children, and is used as a marker of nutritional status in 
other pediatric diseases.8 The BMI provides an objective 
assessment of protein-energy depletion, or excess, and is a 
practical tool for routine anthropometric measures in 
clinics.9
The involvement of nutritional status (anthropomet-
ric and biochemical) has often been reported in JRA pa-
tients, but there are some discordant reports about the 
nutritional status and disease subtypes.9,10 The aim of this 
study was to investigate the relationship between nutri-
tional status measured by BMI, patient characteristics, 
and disease subtypes.
Methods
Patients
Children diagnosed with JRA and treated at National 
Taiwan University Hospital between 1997 and 2004 were 
retrospectively enrolled in this study. The diagnosis and 
classification of JRA were based on the 1977 American 
College of Rheumatology criteria.11 The onset type was 
defined by the manifestations of the disease in the first 
6 months after onset: polyarticular onset (= 5 joints in-
volved), oligoarthritis (= 4 joints involved), and systemic 
onset (predominance of extra-articular features, e.g. fever 
and skin rash). Age at onset was defined as the age of the 
first physical symptoms or signs consistent with the diag-
nosis of JRA. BMI was recorded at a rheumatology clinic. 
This study included 53 JRA patients and 75 age-matched 
children as healthy controls. The BMI records were ob-
tained from the healthy children who were routinely ex-
amined at each term of an elementary school in the same 
city, and who received scheduled vaccinations at our hospi-
tal. Informed consent and ethical approval were obtained.
Data collection
The main outcome measure used to assess nutritional sta-
tus in children in this study was BMI. Patient characteris-
tics considered as explanatory measures were age, gender, 
disease subtype, and duration of disease.
The laboratory parameters were white blood cell (WBC) 
count, platelet count, hemoglobin concentrations, C-reactive 
protein (CRP), erythrocyte sedimentation rate (ESR), C3 and 
C4. All variables were recorded when JRA was diagnosed.
Statistical analysis
Analysis was carried out using SPSS version 13.0 (SPSS 
Inc., Chicago, IL, USA). The age, disease duration, and lab-
oratory parameters are expressed as mean ± standard devi-
ation. A two-sample t test and one-way analysis of variance 
(ANOVA) were used for comparison of scores within sub-
groups. The body height, body weight, and BMI were 
expressed as the median (25th–75th percentile). The Mann-
Whitney U test was used to compare the data between two 
groups. Differences were considered to be significant when 
p ≤ 0.05.
Results
The demographic and clinical characteristics of the pa-
tients are described in Table 1. There were 23 (43.4%) pa-
tients in the oligoarticular group, 11 (20.8%) patients in 
the polyarticular group and 19 (35.8%) patients in the sys-
temic group. The age of disease onset was similar between 
the oligoarticular and the polyarticular group, but lower 
in the systemic group. There was no significant difference 
Table 1. Demographic and clinical characteristics of patients by disease subtypea
 Oligoarticular Polyarticular Systemic Total Control
No. of patients 23 (43.4) 11 (20.8) 19 (35.8) 53 (100) 75 (100)
Gender, male/female 17/6 7/4 7/12 31/22 36/39
Age when BMI recorded (yr) 9.7 ± 3.3 9.4 ± 3.5 6.6 ± 3.9 8.5 ± 3.9 8.0 ± 2.3
Age of disease onset (yr) 8.3 ± 3.1 8.6 ± 4.0 5.7 ± 4.1 7.5 ± 3.8 –
Disease duration (mo) 16.2 ± 13.5 9.2 ± 10.9 10.1 ± 9.8 12.6 ± 12.0 –
aData presented as n (%) or mean ± standard deviation. BMI = body mass index.
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of disease duration among the three disease subtypes 
(p = 0.151).
A comparison of laboratory parameters by disease sub-
types is summarized in Table 2. The WBC count, platelet 
count, level of CRP and ESR were significantly increased in 
the systemic form of JRA. The hemoglobin concentration 
was significantly lower in the systemic form of disease.
Tables 3–5 summarize the difference in body height, 
body weight and BMI between the different subgroups. 
There is no significant difference in body height and body 
weight among the subgroups. The BMI values are not 
significantly different among the three JRA subgroups 
(p = 0.863, data not shown). The BMI of the total JRA 
group is significantly lower than the control group (p = 
0.006), but when the JRA patients and the healthy control 
children are divided by sex, only the male patients have 
lower BMI than that of the male control group (p = 0.016). 
When the JRA patient and healthy children are divided 
into two groups by age (younger or older than 4 years 
of age), the JRA patients older than 4 years of age have 
significantly lower BMI than the healthy control group 
(p = 0.011).
There is a significant difference between the BMI in 
the three disease subtypes and that in the healthy control 
Table 2. Laboratory measurements when disease onseta
Parameters Oligoarticular Polyarticular Systemic p
WBC count (103/μL) 8.4 ± 2.1 8.3 ± 2.4 15.2 ± 10.2 0.004
Platelet count (103/μL) 409 ± 95 384 ± 69 522 ± 185 0.011
Hemoglobin (g/dL) 11.8 ± 0.9 11.6 ± 1.4 9.7 ± 1.8 < 0.001
CRP (mg/dL) 2.04 ± 2.14 3.41 ± 3.88 8.70 ± 4.80 < 0.001
ESR (mm/hr) 48.3 ± 28.9 49.5 ± 29.5 89.3 ± 32.6 0.001
C3 (mg/dL) 156 ± 28 147 ± 23 175 ± 41 0.072
C4 (mg/dL) 33 ± 8.7 35 ± 12.0 32 ± 10.0 0.836
aData presented as mean ± standard deviation. WBC = White blood cell; CRP = C-reactive protein; ESR = erythrocyte sedimentation rate.
Table 3. Difference of body height, body weight and body mass index between patients and healthy normalsa
Characteristics Total JRA (n = 53) Control (n = 75) p
Body height (cm) 132 (111–144) 130 (125–133) 0.315
Body weight (kg) 28 (18.4–37.0) 27.8 (24.0–33.8) 0.701
BMI (kg/m2) 15.32 (14.28–17.9) 16.9 (15.6–20.1) 0.006
Age (yr) 8.5 ± 3.8 8.0 ± 2.3 0.341
aData presented as median (25th–75th percentile) or mean ± standard deviation. JRA = Juvenile rheumatoid arthritis; BMI = body mass index.
Table 4. Difference of body height, body weight and body mass index between patients and healthy controls group in male and 
female patientsa
 Male Female
Characteristics
 JRA (n = 31) Control (n = 36) p JRA (n = 22) Control (n = 39) p
Body height (cm) 137 (119–149) 130 (125–134) 0.082 121 (99–141) 130 (124–133) 0.448
Body weight (kg) 28.3 (21.6–41.2) 29.7 (24–38) 0.845 24.5 (16.5–34.7) 26.9 (22.9–31.7) 0.652
BMI (kg/m2) 15.57 (14.5–17.9) 17.3 (15.6–20.7) 0.016 14.96 (13.90–18.02) 16.35 (15.67–18.67) 0.106
Age (yr) 8.8 ± 4.0 8.1 ± 2.3 0.340 8.0 ± 3.6 7.9 ± 2.4 0.850
aData presented as median (25th–75th percentile) or mean ± standard deviation. BMI = Body mass index.
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group (p = 0.048), and the patients with oligoarticular JRA 
have a significantly lower BMI compared with that of the 
healthy control group (p = 0.012; Figure).
Discussion
In this study, boys outnumber girls in the prevalence of 
JRA, a finding supported by most reports from Asia.12–14 
However, this is different from most Western studies, 
which show a higher prevalence of JRA in girls.15,16 The in-
flammation parameters, including total WBC count, plate-
let count, ESR and CRP were elevated in the systemic onset 
group. This result is also compatible with previous re-
ports,17–19 and indicates progressive systemic inflammation 
in this subtype. In our study, the BMI levels of the JRA pa-
tients were lower than those of the age-matched healthy 
children, especially in the male group, and those over 
4 years old. In addition, the disease subtype associated 
with lower BMI levels was the oligoarticular onset group. 
The ESR and CRP levels did not correlate with the BMI 
within each group (data not shown).
JRA is a heterogeneous group of chronic inflammatory 
diseases, and poor nutritional status is often reported.6 
There are several studies suggesting that different disease 
subtypes and characteristics are associated with poor nu-
tritional status, but no conclusion has been reached.10,20–23 
The poor nutritional status may be the result of (1) in-
creased production of tumor necrosis factor-alpha and 
interleukin-1;24,25 (2) decreased food intake because of 
chronic inflammatory disease, or a side effect of drugs; or 
(3) reduced physical activity.26 Poor nutritional status may 
affect the general well-being of the diseased child, and 
contribute to growth disturbance.9
There is also a study showing reduced fat-free mass 
and a significantly higher resting energy expenditure per 
kilogram of body weight in patients with systemic JRA.27 
In another study, Xavier and colleagues showed that pa-
tients with a systemic, or polyarticular, disease subtype 
tended to present with lower percentiles of BMI.23 It is 
thought that patients with systemic JRA tend to have 
more severe inflammation and disease activity. The nutri-
tional status of these patients should be lower than that 
of the other disease subtypes and healthy controls. How-
ever, our data did not support this notion. In our study, 
the systemic JRA patients had more severe inflammation 
(higher CRP and ESR), but the BMI did not correlate with 
the CRP and ESR level within each subgroup. This may 
Figure. Body mass index among different disease subtypes and 
healthy control group. Significant different in body mass index 
among four groups (Kruskal-Wallis test, p = 0.048) and between 
the oligoarticular and control group (Mann-Whitney U test, 
p = 0.012). JRA = Juvenile rheumatoid arthritis.
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Table 5. Difference of body height, body weight and body mass index between patients and healthy controls in different age 
groupa
 Age < 4 yr Age > 4 yr
Characteristics
 JRA (n = 9) Control (n = 12) p JRA (n = 44) Control (n = 63) p
Body height (cm) 87 (82.5–95.7) 92 (86.8–100) 0.177 136 (120–147) 131 (127–134) 0.081
Body weight (kg) 12.5 (10.1–14.3) 13.3 (11.3–15.6) 0.337 29.9 (22.7–37.3) 29.4 (25.5–36.7) 0.692
BMI (kg/m2) 15.10 (14.65–17.36) 15.80 (15.42–17.18) 0.136 15.72 (14.15–17.9) 17.30 (15.70–20.30) 0.011
Age (yr) 2.8 ± 0.7  2.7 ± 0.8 0.850 9.7 ± 3.0 9.0 ± 0 0.073
aData presented as median (25th–75th percentile) or mean ± standard deviation. BMI = Body mass index.
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suggest that, besides these inflammation factors, some 
undetermined factors affect the nutritional status of JRA 
patients. Cleary et al demonstrated that the most com-
monly affected subtypes were persistent oligoarthritis and 
rheumatoid factor-negative polyarthritis.9 In our unse-
lected sample, the disease subtype associated with lower 
BMI was oligoarthritis, and this result is compatible with 
the study of Cleary et al, but different from other studies. 
Cleary et al postulate that persistent oligoarthritis is not a 
disease which only affects the joints, but may also be as-
sociated with significant systemic upset and that those 
patients may have different cytokine profiles from those 
with other subtypes.9 In the future, other cytokine pro-
files (including leptin) should be studied to understand 
why there are discordant reports about the BMI in JRA 
patients. More data regarding nutritional biomarkers 
such as serum albumin should also be collected in the 
future.
In our study, we also found that the male JRA patients 
have lower BMI levels than their corresponding age-
matched healthy controls, which has not been described 
before. One previous study reported that male patients 
correlate with worse disability in systemic onset JRA, and 
that lower BMI may be one of the reasons.28 In addition, a 
predominance of oligoarticular onset in the male group 
may also have some effect on the statistical results.
In the group containing children younger than 4 years 
old, the patients did not have lower BMI levels than the 
healthy controls. We chose the age of 4 as a cutoff point in 
this study because the BMI level dropped in the healthy 
controls around the age of 4. Therefore, we subdivided 
this group of patients to see whether there was any effect 
on the statistical results, but this had no effect on the 
results.
Pietrobelli and colleagues demonstrated that BMI is 
strongly associated with both total body fat and the per-
centage of body weight as fat in a healthy pediatric popu-
lation.5 Growth, body composition, and timing of puberty 
may also be abnormal in chronic inflammatory disorders. 
This may be a direct result of the disease, or to side effects 
of medication. For example, some children may become 
overweight when they use glucocorticosteroids for long 
periods. This may make the interpretation of the relation-
ship between disease activity, or disease subtypes, and BMI 
more difficult.
In conclusion, the major characteristics of JRA in this 
study included a higher prevalence in boys, lower disease 
onset age in the systemic group, and elevated inflamma-
tion parameters in the systemic group. Our study also 
suggests that, when using BMI as measurement, impaired 
nutritional status has adverse effects on children with JRA 
(especially those with oligoarticular JRA), male patients, 
and those younger than 4 years-old.
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